Manipulate tumor hypoxia for improved photodynamic therapy using nanomaterials
Authors:
- 31 December 2022
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 247, 115084
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21204071, 51773162)
- Wuhan University of Technology
This publication has 126 references indexed in Scilit:
- All-in-One Theranostic Nanoagent with Enhanced Reactive Oxygen Species Generation and Modulating Tumor Microenvironment Ability for Effective Tumor EradicationACS Nano, 2018
- Efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in nasopharyngeal carcinoma in vitro and in vivoCancer Communications, 2018
- Photomixotrophic chemical production in cyanobacteriaCurrent Opinion in Biotechnology, 2018
- Oxygen‐Evolving Mesoporous Organosilica Coated Prussian Blue Nanoplatform for Highly Efficient Photodynamic Therapy of TumorsAdvanced Science, 2018
- O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxiaTheranostics, 2018
- Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responsesNature Communications, 2017
- Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT)Biomaterials Science, 2017
- Overcoming the Achilles' heel of photodynamic therapyChemical Society Reviews, 2016
- Mitochondria and CancerMolecular Cell, 2016
- Selective Tumor Targeting by the Hypoxia-Activated Prodrug AQ4N Blocks Tumor Growth and Metastasis in Preclinical Models of Pancreatic CancerClinical Cancer Research, 2007